# Management of Apnea in Late Preterm and Term Infants

> **NCT02408328** · PHASE2 · WITHDRAWN · sponsor: **Boston Children's Hospital**

## Conditions studied

- Apnea

## Interventions

- **DRUG:** Caffeine citrate
- **DEVICE:** Home monitor
- **OTHER:** Continued inpatient monitoring until apnea resolution

## Key facts

- **NCT ID:** NCT02408328
- **Lead sponsor:** Boston Children's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-06
- **Primary completion:** 2020-12
- **Final completion:** 2021-05
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Transition to new position
- **Last updated:** 2019-10-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02408328

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02408328, "Management of Apnea in Late Preterm and Term Infants". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02408328. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*